Invention Grant
- Patent Title: Anti-CD70 antibody drug conjugates
-
Application No.: US16224346Application Date: 2018-12-18
-
Publication No.: US11459392B2Publication Date: 2022-10-04
- Inventor: Richard S Barnett , Nick Knudsen , Ying Sun , Sandra Biroc , Timothy Buss , Tsotne Javahishvili , Damien Bresson , Shailaja Srinagesh , Amha Hewet , Jason Pinkstaff
- Applicant: Ambrx, Inc.
- Applicant Address: US CA La Jolla
- Assignee: Ambrx, Inc.
- Current Assignee: Ambrx, Inc.
- Current Assignee Address: US CA La Jolla
- Agency: Ambrx, Inc.
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K47/68 ; A61K47/42 ; C07K5/062

Abstract:
This invention relates to anti-CD70 antibodies and antibody drug conjugates comprising at least one non-naturally-encoded amino acid. Disclosed herein are αCD70 antibodies with one or more non-naturally encoded amino acids and further disclosed are antibody drug conjugates wherein the αCD70 antibodies of the invention are conjugated to one or more toxins. Further disclosed are methods for using such non-natural amino acid antibody drug conjugates, including therapeutic, diagnostic, and other biotechnology uses.
Public/Granted literature
- US20190338039A1 ANTI-CD70 ANTIBODY DRUG CONJUGATES Public/Granted day:2019-11-07
Information query